GFP
IONS icon

Gryphon Financial Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Gryphon Financial Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-905
Closed -$38K – 489
2018
Q2 		$38K Hold
905
– – 0.02% 276
2018
Q1 		$40K Sell
905
-119
-12% -$6.05K 0.02% 259
2017
Q4 		$52K Buy
+1,024
New +$56.2K 0.03% 236

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Gryphon Financial Partners's IONS Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Ionis Pharmaceuticals (IONS) in Q3 2018, closing a stake of 905 shares — an estimated $38K sold.

Gryphon Financial Partners first reported a position in IONS in Q4 2017 and held it in 3 quarters. The position peaked at $52K in Q4 2017. 322 funds tracked by Wall St. Rank hold IONS as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Ionis Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 905 Ionis Pharmaceuticals shares in Q3 2018, an estimated $38K.
  • Gryphon Financial Partners first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Gryphon Financial Partners's Ionis Pharmaceuticals position peaked at $52K in Q4 2017.
  • 322 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.